Large outcome trials demonstrated that several GLP-1 agonists significantly reduce major adverse cardiovascular events (heart attack, stroke, cardiovascular death) in patients with type 2 diabetes
Together, these two drugs reduce hunger, increase satiety, and lower total daily calorie intake without requiring the patient to consciously restrict every meal
So unless you include regular exercise as part of your weight loss program, the weight you lose while taking Ozempic, Wegovy, Mounjaro or Zepbound will include both muscle and fat, but the weight you will regain after stopping the GLP-1 will be mostly fat, leaving you metabolically even worse off than when you started
Clear explanations of the ingredients used
It protects cells from oxidative stress, supports liver detoxification, and plays a role in immune function and mitochondrial health